SC
INSM icon

SummitTX Capital’s Insmed INSM Stock Holding History

SummitTX Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79M Sell
23,153
-2,814
-11% -$433K 0.12% 205
2025
Q4 		$4.52M Buy
25,967
+17,167
+195% +$3.13M 0.14% 172
2025
Q3 		$1.27M Sell
8,800
-10,281
-54% -$1.26M 0.05% 335
2025
Q2 		$1.92M Buy
19,081
+1,153
+6% +$88.2K 0.08% 261
2025
Q1 		$1.37M Buy
+17,928
New +$1.37M 0.06% 326

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SummitTX Capital's INSM Position: Q1 2026 in Review

SummitTX Capital reduced its Insmed (INSM) stake by 11% in Q1 2026, selling an estimated $433K and leaving 23,153 shares worth $3.79M. The position accounts for 0.12% of the portfolio, ranked #205.

SummitTX Capital first reported a position in INSM in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.52M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • SummitTX Capital held 23,153 shares of Insmed worth $3.79M as of Q1 2026.
  • SummitTX Capital sold 2,814 Insmed shares in Q1 2026, an estimated $433K.
  • Insmed made up 0.12% of SummitTX Capital's portfolio in Q1 2026, its #205 holding.
  • SummitTX Capital first reported a position in Insmed in Q1 2025 and has held it in 5 quarters since.
  • SummitTX Capital's Insmed position peaked at $4.52M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.